Literature DB >> 16078080

Identification of RNA-binding regions on the P and V proteins of human parainfluenza virus type 2.

Machiko Nishio1, Masato Tsurudome, Morihiro Ito, Yasuhiko Ito.   

Abstract

We have shown that the P and V proteins of human parainfluenza virus type 2 (hPIV-2) bind to genomic RNA by using Northwestern blot analysis. To identify the RNA-binding regions on the P and V proteins, we used a set of deletion mutants produced in Escherichia coli. One region required for the RNA-binding was found in the P-V common domain (aa 1-82). Others were found in the P protein-specific region (aa 249-354) and the V protein-specific region (aa 176-225). In addition, we have shown that substitutions of some basic residues with alanines in these regions abrogate RNA-binding by the P or V proteins. Intriguingly, the P and V proteins of hPIV2 can selectively bind to the viral RNA under our experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078080     DOI: 10.1007/s00430-005-0244-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

Review 1.  Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.

Authors:  E C LaCasse; Y A Lefebvre
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

2.  Sequence analysis of P gene of human parainfluenza type 2 virus: P and cysteine-rich proteins are translated by two mRNAs that differ by two nontemplated G residues.

Authors:  S Ohgimoto; H Bando; M Kawano; K Okamoto; K Kondo; M Tsurudome; M Nishio; Y Ito
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

3.  Binding of the V proteins to the nucleocapsid proteins of human parainfluenza type 2 virus.

Authors:  N Watanabe; M Kawano; M Tsurudome; M Nishio; M Ito; S Ohgimoto; S Suga; H Komada; Y Ito
Journal:  Med Microbiol Immunol       Date:  1996-09       Impact factor: 3.402

4.  Human parainfluenza virus type 2 phosphoprotein: mapping of monoclonal antibody epitopes and location of the multimerization domain.

Authors:  M Nishio; M Tsurudome; M Ito; N Watanabe; M Kawano; H Komada; Y Ito
Journal:  J Gen Virol       Date:  1997-06       Impact factor: 3.891

5.  Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.

Authors:  M Nishio; M Tsurudome; M Kawano; N Watanabe; S Ohgimoto; M Ito; H Komada; Y Ito
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

6.  Isolation of monoclonal antibodies directed against the V protein of human parainfluenza virus type 2 and localization of the V protein in virus-infected cells.

Authors:  M Nishio; M Tsurudome; M Ito; M Kawano; S Kusagawa; H Komada; Y Ito
Journal:  Med Microbiol Immunol       Date:  1999-11       Impact factor: 3.402

7.  Mapping of domains on the human parainfluenza virus type 2 nucleocapsid protein (NP) required for NP-phosphoprotein or NP-NP interaction.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Mitsuo Kawano; Shigeru Kusagawa; Hiroshi Komada; Yasuhiko Ito
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

8.  Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein.

Authors:  K Watanabe; H Handa; K Mizumoto; K Nagata
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues.

Authors:  Lorena Rodríguez; Isabel Cuesta; Ana Asenjo; Nieves Villanueva
Journal:  J Gen Virol       Date:  2004-03       Impact factor: 3.891

10.  The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties.

Authors:  F Xavier Gomis-Rüth; Andréa Dessen; Joanna Timmins; Andreas Bracher; Larissa Kolesnikowa; Stephan Becker; Hans Dieter Klenk; Winfried Weissenhorn
Journal:  Structure       Date:  2003-04       Impact factor: 5.006

View more
  3 in total

1.  Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Emerito Amaro-Carambot; Sheila M Nolan; Stephanie Davis; Shenelle-Marie Wise; Caraline Higgins; Konrad Bradley; Olivia Kim; Reina Mayor; Mario H Skiadopoulos; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2010-07-27       Impact factor: 3.616

2.  Human parainfluenza virus type 2 V protein inhibits genome replication by binding to the L protein: possible role in promoting viral fitness.

Authors:  Machiko Nishio; Junpei Ohtsuka; Masato Tsurudome; Tetsuya Nosaka; Daniel Kolakofsky
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

3.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.